Skip to main content

Non-Small Cell Lung Cancer News

Related terms: Cancer, Lung, Non-Small Cell, Lung Cancer, Non-Small Cell, NSCLC

Immune Checkpoint Inhibitor Affordability Tied to Widening Survival Disparity

FRIDAY, July 11, 2025 – The introduction of immune checkpoint inhibitors (ICIs) was associated with a widening survival disparity between those with private insurance and those without health...

FDA Grants Accelerated Approval to Zegfrovy (sunvozertinib) for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

July 2, 2025 – Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that the U.S. Food and D...

Clash Of Drugs Impedes Lung Cancer Treatment, Lowers Survival

TUESDAY, July 7, 2025 — Two drugs used in lung cancer treatment appear to be tripping over each other, reducing patients’ chances for a cure, a new study says. Corticosteroids are commonly prescribed ...

Clash Of Drugs Impedes Lung Cancer Treatment, Lowers Survival

TUESDAY, July 7, 2025 — Two drugs used in lung cancer treatment appear to be tripping over each other, reducing patients’ chances for a cure, a new study says. Corticosteroids are commonly prescribed ...

Datroway Approved in the U.S. as First TROP2 Directed Therapy for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer

Tokyo and Basking Ridge, NJ – June 23, 2025 – Datroway (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the treatment of adult patients with locally advanced or metastatic EGFR-mutated ...

FDA Approves Ibtrozi (taletrectinib) for Advanced ROS1-Positive Non-Small Cell Lung Cancer

NEW YORK--(BUSINESS WIRE) June 11, 2025 – Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that the...

American Society of Clinical Oncology, May 31-June 3

The annual meeting of the American Society of Clinical Oncology was held from May 31 to June 3 in Chicago and hosted more than 35,000 participants, including clinicians, academicians, allied health p...

Wildfire Smoke Dents Survival Odds For Lung Cancer Patients

MONDAY, June 2, 2025 — Wildfire smoke could make it harder for people with lung cancer to survive, a new study says. Californians with lung cancer who breathed smoke from wildfires had a 20% i...

FDA Grants Accelerated Approval to Emrelis (telisotuzumab vedotin-tllv) for Non-Small Cell Lung Cancer With High c-Met Protein Overexpression

NORTH CHICAGO, Ill., May 14, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that Emrelis (telisotuzumab vedotin-tllv) has been granted accelerated approval by the U.S. Food and Drug Adm...

Double Lung Transplant Saves Mother Of Twins

MONDAY, May 12, 2025 — The timing of Cornelia Tischmacher’s pneumonia couldn’t have been worse — eight months after the Berlin mom gave birth to twins. But the pneumonia just wouldn’t go away, so Tisc...

Durable Disease Control Possible After Stopping Immune Checkpoint Inhibitors in NSCLC

TUESDAY, April 22, 2025 – Prolonged disease control can be maintained for patients with advanced non-small cell lung cancer (NSCLC) who discontinue immune checkpoint inhibitors (ICIs) for...

Lung Cancer Remains At Bay Long After Immune Therapy Is Dropped

MONDAY, April 21, 2025 — Immunotherapy might help keep lung cancer at bay for months or even years after the treatment has been abandoned due to side effects, a new study says. Immune checkpoint i...

More Than 3.8 Million U.S. Lung Cancer Deaths Averted During 1970 to 2022

TUESDAY, April 1, 2025 – More than 3.8 million U.S. lung cancer deaths were averted during 1970 to 2022, and more than 76 million person-years of life were gained, according to a study published...

Lung Cancer Screening Rates Increased After 2021 Update to USPSTF Guidelines

MONDAY, March 31, 2025 – Increased lung cancer screening uptake was seen after the 2021 update to the U.S. Preventive Services Task Force (USPSTF) guidelines, which expanded eligibility criteria to...

Molecular Residual Disease Analysis May Predict Disease Recurrence After Lung Cancer Resection

TUESDAY, March 25, 2025 – For patients with resected stage IB-IIIA epidermal growth factor receptor-mutated non-small cell lung cancer, molecular residual disease (MRD) precedes disease-free...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Lung Cancer

Related drug support groups

methotrexate, Keytruda, Opdivo, docetaxel